TY - JOUR
T1 - Risk of critical limb ischemia in long-term uterine cancer survivors
T2 - A population-based study
AU - Chen, Min Chi
AU - Chang, Jung Jung
AU - Chen, Miao Fen
AU - Wang, Ting Yao
AU - Huang, Cih En
AU - Lee, Kuan Der
AU - Chen, Chao Yu
N1 - Funding Information:
Supported by the Chang Gung Medical Foundation, Taiwan, No. CMRPD1J0101-0102.
Publisher Copyright:
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All Rights Reserved.
PY - 2022/12
Y1 - 2022/12
N2 - BACKGROUND The risk of critical limb ischemia (CLI) which causes ischemic pain or ischemic loss in the arteries of the lower extremities in long-term uterine cancer (UC) survivors remains unclear, especially in Asian patients, who are younger at the diagnosis of UC than their Western counterparts. AIM To conduct a nationwide population-based study to assess the risk of CLI in UC long-term survivors. METHODS UC survivors, defined as those who survived for longer than 5 years after the diagnosis, were identified and matched at a 1:4 ratio with normal controls. Stratified Cox models were used to assess the risk of CLI. RESULTS From 2000 to 2005, 1889 UC survivors who received surgery alone or surgery combined with radiotherapy (RT) were classified into younger (onset age < 50 years, n = 894) and older (onset age ≥ 50 years, n = 995) groups. While compared with normal controls, the younger patients with diabetes, hypertension, and receiving hormone replacement therapy (HRT) were more likely to develop CLI. In contrast, the risk of CLI was associated with adjuvant RT, obesity, hypertension, and HRT in the older group. Among the UC survivors, those who were diagnosed at an advanced age (> 65 years, aHR = 2.48, P = 0.011), had hypertension (aHR = 2.18, P = 0.008) or received HRT (aHR = 3.52, P = 0.020) were at a higher risk of CLI. CONCLUSION In this nationwide study, we found that the risk factors associated with CLI were similar in both cohorts except for adjuvant RT that was negligible in the younger group, but positive in the older group. Among the survivors, hypertension, advanced age, and HRT were more hazardous than RT. Secondary prevention should include CLI as a late complication in UC survivorship programs.
AB - BACKGROUND The risk of critical limb ischemia (CLI) which causes ischemic pain or ischemic loss in the arteries of the lower extremities in long-term uterine cancer (UC) survivors remains unclear, especially in Asian patients, who are younger at the diagnosis of UC than their Western counterparts. AIM To conduct a nationwide population-based study to assess the risk of CLI in UC long-term survivors. METHODS UC survivors, defined as those who survived for longer than 5 years after the diagnosis, were identified and matched at a 1:4 ratio with normal controls. Stratified Cox models were used to assess the risk of CLI. RESULTS From 2000 to 2005, 1889 UC survivors who received surgery alone or surgery combined with radiotherapy (RT) were classified into younger (onset age < 50 years, n = 894) and older (onset age ≥ 50 years, n = 995) groups. While compared with normal controls, the younger patients with diabetes, hypertension, and receiving hormone replacement therapy (HRT) were more likely to develop CLI. In contrast, the risk of CLI was associated with adjuvant RT, obesity, hypertension, and HRT in the older group. Among the UC survivors, those who were diagnosed at an advanced age (> 65 years, aHR = 2.48, P = 0.011), had hypertension (aHR = 2.18, P = 0.008) or received HRT (aHR = 3.52, P = 0.020) were at a higher risk of CLI. CONCLUSION In this nationwide study, we found that the risk factors associated with CLI were similar in both cohorts except for adjuvant RT that was negligible in the younger group, but positive in the older group. Among the survivors, hypertension, advanced age, and HRT were more hazardous than RT. Secondary prevention should include CLI as a late complication in UC survivorship programs.
KW - Critical limb ischemia
KW - Radiotherapy
KW - Survivorship
KW - Uterine cancer
UR - http://www.scopus.com/inward/record.url?scp=85145940650&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145940650&partnerID=8YFLogxK
U2 - 10.12998/wjcc.v10.i36.13293
DO - 10.12998/wjcc.v10.i36.13293
M3 - Article
AN - SCOPUS:85145940650
SN - 2307-8960
VL - 10
SP - 13293
EP - 13303
JO - World Journal of Clinical Cases
JF - World Journal of Clinical Cases
IS - 36
ER -